Funding Partnerships The AIM-HI Accelerator Fund is a 501(C)(3) non-profit financing oncology startups and has recent activity investing in DotBio Pte. Ltd. This indicates potential for collaboration on grant-funded programs, sponsored research, or co-investment opportunities with biotech startups in the cancer therapy space.

Women’s Venture AIM-HI runs Women’s Venture Competitions and Women’s Initiatives programs to empower underfunded women scientist-entrepreneurs. This presents an avenue to engage with female-led oncology ventures as potential partners, co-sponsors, or deal flow sources for franchised accelerator support.

Global Advocate Leadership and global advocacy recognition for AIM-HI leadership enhances credibility with researchers and institutions. Use this visibility to introduce strategic partnerships with universities, research consortia, and corporate sponsors seeking trusted players in cancer translational work.

Tech & Ops Their tech stack includes HubSpot, AWS, WordPress, Shopify, Microsoft 365, WhatsApp Business, Stripe, and Imperva, signaling mature digital operations. This supports scalable outreach, donor stewardship, event commerce, and secure collaboration with portfolio companies.

Funding Scale Funding and revenue are modest (<1M), suggesting a sweet spot for mid-stage collaborations, co-funding opportunities, grant alignment, and services tailored to lean, mission-driven oncology ventures seeking non-dilutive or strategic support.